$162.30
2.621.64%
At close: -
$162.40
0.10.06%
After Hours: 7:33 PM EDT
Comments
Loading...
Latest news for Johnson & Johnson (NYSE:JNJ) Stock
Johnson & Johnson Stock (NYSE: JNJ)
Categories: All
Friday, February 21, 2025
Thursday, February 20, 2025
Wednesday, February 19, 2025
Tuesday, February 18, 2025
Friday, February 14, 2025
Thursday, February 13, 2025
Wednesday, February 12, 2025
Tuesday, February 11, 2025
Sunday, February 09, 2025
Friday, February 07, 2025
Thursday, February 06, 2025
Monday, February 03, 2025
Thursday, January 30, 2025
Wednesday, January 29, 2025
- RFK Jr. And Big Pharma: Health Secretary Hopeful Answers Pointed Questions On Drugs, Insurance, Trump Exec Orders
- Starbucks To Rally Over 23%? Here Are 10 Top Analyst Forecasts For Wednesday
- Marjorie Taylor Greene Loads Up On Meta, Amazon, Tesla, Nvidia And Other Stocks As Donald Trump's New Equations With Big Tech Leaders Sets Stage For Growth: What Is At Stake? (UPDATED)
Tuesday, January 28, 2025
Monday, January 27, 2025
Thursday, January 23, 2025
- Johnson & Johnson's MedTech Momentum Expected To Rebound In 2025 Despite Current Hurdles: Analyst
- Where Johnson & Johnson Stands With Analysts
- 'Purdue Pharma's Sacklers Strike New $6.5 Bil...
- RBC Capital Reiterates Outperform on Johnson ...
- Morgan Stanley Maintains Equal-Weight on John...
- Stifel Maintains Hold on Johnson & Johnson, L...
- Leerink Partners Maintains Outperform on John...
- Wells Fargo Maintains Equal-Weight on Johnson...
- Raymond James Maintains Outperform on Johnson...
- B of A Securities Maintains Neutral on Johnso...
- Johnson & Johnson Reports Publication Of Find...
Wednesday, January 22, 2025
- S&P 500 Hits Fresh Records At 6,100: Strong Earnings, Trump's AI Wager Fuel Bull Run
- Cytokinetics Heart Drug's Future Sparks Optimism Despite M&A Hurdles and Royalty Deal Concerns: Analyst
- Chipmakers Rally On AI Stargate Bet, Netflix Soars, Bitcoin Falters As Trump Keeps Quiet On Crypto: What's Driving Markets Wednesday?
- Johnson & Johnson Q4 Earnings: Cancer Drugs Performance Drives Revenue Beat, Issues Strong FY25 Outlook
- Johnson & Johnson shares are trading higher a...
- Johnson & Johnson Expects 2025 Adjusted EPS O...
- Johnson & Johnson Expects 2025 Sales Of $90.9...
- Johnson & Johnson Q4 2024 Adj EPS $2.04 Beats...
- US Stocks Likely To Open Higher As Trump Announces $500 Billion AI Project: Oracle, Netflix, Nvidia Among Top Stocks To Watch
- Earnings Scheduled For January 22, 2025
- Dow Jumps Over 500 Points As Trump Takes Office: Investor Sentiment Improves, But Greed Index Remains In 'Fear' Zone